# Appetite and drinking studies

> Read the studies | Semaglutide New York — The Semaglutide New York reading list: alcohol consumption, rodent appetite pathways, safety, body weight and heart and kidney outcomes.

**The reading table**

The human alcohol experiment, the animal work around it, and the weight and safety papers that keep the question grounded.

## A starting stack

Start with the [randomized trial in adults with alcohol use disorder](https://pubmed.ncbi.nlm.nih.gov/39937469/). The [rodent food-intake and food-preference study](https://pubmed.ncbi.nlm.nih.gov/32213703/) offers a related biological question, and the [mechanistic review](https://pubmed.ncbi.nlm.nih.gov/39728000/) gives that animal work a wider context.

For a different scale of human evidence, there is [STEP 1](https://pubmed.ncbi.nlm.nih.gov/33567185/). For the less comfortable part of the dinner conversation, read the [semaglutide safety review](https://pubmed.ncbi.nlm.nih.gov/34305810/). The full list below also includes the cardiovascular, kidney and diabetes eye-complication sources used in these essays.

## References

[1] Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/39937469/
[2] Semaglutide lowers body weight in rodents via distributed neural pathways https://pubmed.ncbi.nlm.nih.gov/32213703/
[3] Spotlight on the Mechanism of Action of Semaglutide https://pubmed.ncbi.nlm.nih.gov/39728000/
[4] Safety of Semaglutide https://pubmed.ncbi.nlm.nih.gov/34305810/
[5] Once-Weekly Semaglutide in Adults with Overweight or Obesity https://pubmed.ncbi.nlm.nih.gov/33567185/
[6] Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes https://pubmed.ncbi.nlm.nih.gov/37952131/
[7] Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://pubmed.ncbi.nlm.nih.gov/38785209/
[8] Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://pubmed.ncbi.nlm.nih.gov/27633186/

---

At this editorial table I argue with published research on appetite and drinking; Semaglutide New York is no business, and these essays offer no medical advice.